Evonik Industries AG (FRA:EVK) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of EVK, it is a well-regarded dividend-paying company with a a great track record of delivering benchmark-beating performance. Below, I’ve touched on some key aspects you should know on a high level. If you’re interested in understanding beyond my high-level commentary, read the full report on Evonik Industries here.
Proven track record average dividend payer
Over the past year, EVK has grown its earnings by 44%, with its most recent figure exceeding its annual average over the past five years. Not only did EVK outperformed its past performance, its growth also exceeded the Chemicals industry expansion, which generated a 18% earnings growth. This is an notable feat for the company.
EVK is considered one of the top dividend payers in the market, and it has also been able to maintain it at a level in which net income is able to cover dividend payments.
For Evonik Industries, there are three important factors you should further examine:
- Future Outlook: What are well-informed industry analysts predicting for EVK’s future growth? Take a look at our free research report of analyst consensus for EVK’s outlook.
- Financial Health: Are EVK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of EVK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at firstname.lastname@example.org.